Orthofix (OFIX -16%) takes one in the kisser today after its Q1 showed up missing a few teeth late yesterday. Net sales were were down 14% from the prior year, hit by negative foreign currency translation and two less selling days. Mizuho and Janney Mongomery both cut their rating on the shares to Neutral on the back of the report, while JMP Securities lowered it to Market Perform and Lazard cut it to a Sell.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs